Difference in medication trajectories between subgroups of patients with type 2 diabetes.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Diabetes, insulin and cancer risk The molecular role of insulin signaling and hyperinsulinemia in cancer development and progression in diabetes patients
Dopper, I. (2014)The relationship between diabetes and the risk for cancer development seems to be more and more confirmed. An important link between these two is the hyperinsulinemia found both in patients with T1DM and patients with T2DM. ... -
Kan een interventie met Q-zorgprofielen helpen in de spreekkamer om in gesprek te komen met adolescenten met Diabetes Mellitus type I?: Exploratief pilot-onderzoek
Wagemaker, J.D.M. (2010)Will an intervention with Q-care profiles improve the quality of the dialogue during outpatient center visits with adolescents with Diabetes Mellitus type I; A explorative Pilot study Jacobien Wagemakera,b,c, Susan ... -
Potential new sources for beta-cell replacement therapy in diabetes type 1 patients
Penders, A.F. (2010)Long term complications in diabetes patients are a consequence of the constantly high blood glucose levels, hyperglycemia. In patients with type 1 diabetes hyperglycemia is caused by the absence of insulin production by ...